Oruka Therapeutics (ORKA) EBIT (2010 - 2024)
Oruka Therapeutics' (ORKA) quarterly EBIT came in at -$3.1 million in Q2 2024, down 58.24% year-on-year from -$7.5 million in Q3 2023, and down 25.79% quarter-over-quarter from -$2.5 million in Q1 2024.
Oruka Therapeutics (ORKA) EBIT (2010 - 2024) Analysis & Trends
Oruka Therapeutics' EBIT history runs 15 years deep, the most recent figure standing at -$3.1 million for Q2 2024.
- On a quarterly basis, EBIT fell 58.24% year-over-year to -$3.1 million in Q2 2024; TTM through Jun 2024 was -$9.1 million, a 16.04% decrease from a year earlier, with the FY2023 full-year figure at -$7.3 million, up 31.14% from the prior year.
- EBIT fell to -$3.1 million in Q2 2024 per ORKA's latest filing, from -$2.5 million in the prior quarter.
- Across five years, EBIT topped out at -$1.3 million in Q2 2020 and bottomed at -$5.7 million in Q4 2021.
- The 5-year median for EBIT is -$2.5 million (2022), against an average of -$2.9 million.
- Across the five-year window, EBIT slumped 301.1% in 2020 and surged 72.75% in 2022, its largest moves.
- Year by year, EBIT stood at -$5.1 million in 2020, then slipped by 10.81% to -$5.7 million in 2021, then jumped by 72.75% to -$1.5 million in 2022, then dropped by 2.71% to -$1.6 million in 2023, then plunged by 96.35% to -$3.1 million in 2024.
- Per Business Quant, the three latest ORKA EBIT figures stand at -$3.1 million (Q2 2024), -$2.5 million (Q1 2024), and -$1.6 million (Q4 2023).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -27.75 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 249.90 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -3.72 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 1.14 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 642.90 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | -32.68 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 493.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | -445.22 Mn |
| 10 | Oruka Therapeutics | 36.09 Mn | -795.06 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | -3.12 Mn |
| Mar 31, 2024 | -2.48 Mn |
| Dec 31, 2023 | -1.59 Mn |
| Sep 30, 2023 | -1.94 Mn |
| Jun 30, 2023 | -1.97 Mn |
| Mar 31, 2023 | -1.80 Mn |
| Dec 31, 2022 | -1.55 Mn |
| Sep 30, 2022 | -2.55 Mn |
| Jun 30, 2022 | -3.22 Mn |
| Mar 31, 2022 | -3.28 Mn |
| Dec 31, 2021 | -5.68 Mn |
| Sep 30, 2021 | -4.72 Mn |
| Jun 30, 2021 | -4.84 Mn |
| Mar 31, 2021 | -4.10 Mn |
| Dec 31, 2020 | -5.13 Mn |
| Sep 30, 2020 | -1.99 Mn |
| Jun 30, 2020 | -1.31 Mn |
| Mar 31, 2020 | -1.34 Mn |
| Dec 31, 2019 | -1.28 Mn |
| Sep 30, 2019 | -1.25 Mn |